Research programme: atherosclerosis therapeutics - Phosphagenics

Drug Profile

Research programme: atherosclerosis therapeutics - Phosphagenics

Alternative Names: APA-01; APA-02; Tocopherol derivatives

Latest Information Update: 19 Jan 2011

Price : $50

At a glance

  • Originator Phosphagenics
  • Class Tocopherols
  • Mechanism of Action Antioxidants; Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Atherosclerosis

Most Recent Events

  • 05 Feb 2008 Pharmacodynamics data from a preclinical in Atherosclerosis released by Phosphagenics
  • 22 Jan 2008 Preclinical development is ongoing
  • 24 Aug 2005 Preclinical trials in Atherosclerosis in Switzerland (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top